These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 27314831)
1. Association Between Tissue Inhibitor of Metalloproteinase-3 Gene Methylation and Gastric Cancer Risk: A Meta-Analysis. Cao J; Li Z; Yang L; Liu C; Luan X Genet Test Mol Biomarkers; 2016 Aug; 20(8):427-31. PubMed ID: 27314831 [TBL] [Abstract][Full Text] [Related]
2. Association of RASSF1A promoter methylation with gastric cancer risk: a meta-analysis. Shi DT; Han M; Gao N; Tian W; Chen W Tumour Biol; 2014 Feb; 35(2):943-8. PubMed ID: 23982879 [TBL] [Abstract][Full Text] [Related]
3. Methylated TIMP-3 DNA in body fluids is an independent prognostic factor for gastric cancer. Yu JL; Lv P; Han J; Zhu X; Hong LL; Zhu WY; Wang XB; Wu YC; Li P; Ling ZQ Arch Pathol Lab Med; 2014 Nov; 138(11):1466-73. PubMed ID: 25357107 [TBL] [Abstract][Full Text] [Related]
4. Association of genetic variants in and promoter hypermethylation of CDH1 with gastric cancer: a meta-analysis. Jing H; Dai F; Zhao C; Yang J; Li L; Kota P; Mao L; Xiang K; Zheng C; Yang J Medicine (Baltimore); 2014 Oct; 93(19):e107. PubMed ID: 25340495 [TBL] [Abstract][Full Text] [Related]
5. Association of p16 gene methylation with prostate cancer risk: a meta-analysis. Feng W; Han Z; Zhu R; Liu P; Liu S J BUON; 2015; 20(4):1074-80. PubMed ID: 26416059 [TBL] [Abstract][Full Text] [Related]
6. The association between runt-related transcription factor 3 gene promoter methylation and gastric cancer: A meta-analysis. Liu X; Wang L; Guo Y J Cancer Res Ther; 2016 Oct; 12(Supplement):50-53. PubMed ID: 27721253 [TBL] [Abstract][Full Text] [Related]
7. The relationship between RASSF1A gene promoter methylation and the susceptibility and prognosis of melanoma: A meta-analysis and bioinformatics. Shao C; Dai W; Li H; Tang W; Jia S; Wu X; Luo Y PLoS One; 2017; 12(2):e0171676. PubMed ID: 28207831 [TBL] [Abstract][Full Text] [Related]
8. Positive correlation of tissue inhibitor of metalloproteinase-3 and death-associated protein kinase hypermethylation in head and neck squamous cell carcinoma. Nayak CS; Carvalho AL; Jeronimo C; Henrique R; Kim MM; Hoque MO; Chang S; Jiang WW; Koch W; Westra W; Sidransky D; Califano J Laryngoscope; 2007 Aug; 117(8):1376-80. PubMed ID: 17592394 [TBL] [Abstract][Full Text] [Related]
9. Frequent loss of TIMP-3 expression in progression of esophageal and gastric adenocarcinomas. Gu P; Xing X; Tänzer M; Röcken C; Weichert W; Ivanauskas A; Pross M; Peitz U; Malfertheiner P; Schmid RM; Ebert MP Neoplasia; 2008 Jun; 10(6):563-72. PubMed ID: 18516293 [TBL] [Abstract][Full Text] [Related]
10. CpG island methylation in premalignant stages of gastric carcinoma. Kang GH; Shim YH; Jung HY; Kim WH; Ro JY; Rhyu MG Cancer Res; 2001 Apr; 61(7):2847-51. PubMed ID: 11306456 [TBL] [Abstract][Full Text] [Related]
11. Transcriptional inactivation of the tissue inhibitor of metalloproteinase-3 gene by dna hypermethylation of the 5'-CpG island in human gastric cancer cell lines. Kang SH; Choi HH; Kim SG; Jong HS; Kim NK; Kim SJ; Bang YJ Int J Cancer; 2000 Jun; 86(5):632-5. PubMed ID: 10797283 [TBL] [Abstract][Full Text] [Related]
12. A systematic review and meta-analysis of runt-related transcription factor 3 gene promoter hypermethylation and risk of gastric cancer. Xia Y; Zhang M; Zhang X; Liu X J Cancer Res Ther; 2014 Dec; 10 Suppl():310-3. PubMed ID: 25693942 [TBL] [Abstract][Full Text] [Related]
13. Association between RUNX3 promoter methylation and gastric cancer: a meta-analysis. Fan XY; Hu XL; Han TM; Wang NN; Zhu YM; Hu W; Ma ZH; Zhang CJ; Xu X; Ye ZY; Han CM; Pan WS BMC Gastroenterol; 2011 Aug; 11():92. PubMed ID: 21867527 [TBL] [Abstract][Full Text] [Related]
14. [Relationship between TIMP-3 expression and promoter methylation of TIMP-3 gene in hepatocellular carcinoma]. Lü GL; Wen JM; Xu JM; Zhang M; Xu RB; Tian BL Zhonghua Bing Li Xue Za Zhi; 2003 Jun; 32(3):230-3. PubMed ID: 12882688 [TBL] [Abstract][Full Text] [Related]
15. Methylation-associated silencing of the tissue inhibitor of metalloproteinase-3 gene suggest a suppressor role in kidney, brain, and other human cancers. Bachman KE; Herman JG; Corn PG; Merlo A; Costello JF; Cavenee WK; Baylin SB; Graff JR Cancer Res; 1999 Feb; 59(4):798-802. PubMed ID: 10029065 [TBL] [Abstract][Full Text] [Related]
16. Association of IL-6 polymorphisms with gastric cancer risk: evidences from a meta-analysis. Wang J; He W; Liu J; Nong L; Wei Y; Yang F Cytokine; 2012 Jul; 59(1):176-83. PubMed ID: 22554382 [TBL] [Abstract][Full Text] [Related]
17. The association between CDH1 promoter methylation and patients with ovarian cancer: a systematic meta-analysis. Wang Q; Wang B; Zhang YM; Wang W J Ovarian Res; 2016 Apr; 9():23. PubMed ID: 27067410 [TBL] [Abstract][Full Text] [Related]
18. Risk prediction of gastric cancer by analysis of aberrant DNA methylation in non-neoplastic gastric epithelium. Tahara T; Arisawa T; Shibata T; Wang FY; Nakamura M; Sakata M; Nagasaka M; Takagi T; Kamiya Y; Fujita H; Nakamura M; Hasegawa S; Iwata M; Takahama K; Watanabe M; Hirata I; Nakano H Digestion; 2007; 75(1):54-61. PubMed ID: 17438355 [TBL] [Abstract][Full Text] [Related]
20. A Systematic Analysis of the Relationship of CDH13 Promoter Methylation and Breast Cancer Risk and Prognosis. Yang J; Niu H; Huang Y; Yang K PLoS One; 2016; 11(5):e0149185. PubMed ID: 27153114 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]